Testing of Innocuousness of Benzalkonium Chloride on the Eye Concerning Possible Growth of Langerhans Cells
Sponsor: Merck Sharp & Dohme LLC
A PHASE1 clinical study on Eye Diseases, this trial is ongoing. The trial is conducted by Merck Sharp & Dohme LLC and has accumulated 5 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Jun 2022 — Jul 2024 [monthly]
Unknown Status PHASE1
-
Jan 2021 — Jun 2022 [monthly]
Unknown Status PHASE1
-
Jan 2017 — Jan 2021 [monthly]
Unknown Status PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Merck Sharp & Dohme LLC
- University of Rostock
For direct contact, visit the study record on ClinicalTrials.gov .